The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost ...

Geojit Financial Services shares fell over 6% after disappointing Q1 FY26 results, with net profit dropping 37% ...

ASML Holding's Q2 earnings exceeded expectations with strong sales, high gross margins, and robust share buybacks. Read why I ...

Axis Bank reported a 4 percent year-on-year drop in net profit to Rs 6,034 crore for Q1FY26 as a one-time “technical impact” ...

Opening a busy week of earnings set to be dominated by big banks and tech giants like Netflix, industrial supplier Fastenal ...

The upcoming second-quarter earnings season is expected to shift the focus of Wall Street from the ongoing trade war to the ...

With the stock sporting a triple-digit price-to-earnings ratio (and that's on a forward-looking basis), the case for buying ...

JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.

Alternatively, if you seek upside with a smoother journey than a single stock like Levi Strauss, consider the High Quality ...

ASML Holding N.V. beats Q2 expectations with strong bookings and 2025 guidance. Click for my updated look at ASML earnings ...

Profits for S&P 500 companies in the second quarter are expected to rise 5.8%, according to LSEG data, down from a forecast ...

Stocks post modest gains despite Trump's 30% tariff threats on EU and Mexico as investors focus on upcoming earnings season and negotiations.